These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22926568)

  • 1. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Vu DH; Bolhuis MS; Koster RA; Greijdanus B; de Lange WC; van Altena R; Brouwers JR; Uges DR; Alffenaar JW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5758-63. PubMed ID: 22926568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
    Bolhuis MS; van Altena R; van Hateren K; de Lange WC; Greijdanus B; Uges DR; Kosterink JG; van der Werf TS; Alffenaar JW
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3676-80. PubMed ID: 23689722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
    Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
    Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.
    Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():42-7. PubMed ID: 23973533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
    Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
    Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
    Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
    Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
    Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis.
    Padayatchi N; Mac Kenzie WR; Hirsch-Moverman Y; Feng PJ; Villarino E; Saukkonen J; Heilig CM; Weiner M; El-Sadr WM
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1582-7. PubMed ID: 23131255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
    Bolhuis MS; van Altena R; van Soolingen D; de Lange WC; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
    Eur Respir J; 2013 Dec; 42(6):1614-21. PubMed ID: 23520311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone penetration of linezolid in osteoarticular tuberculosis patients of China.
    Wen S; Zhang T; Yu X; Dong W; Lan T; Fan J; Xue Y; Wang F; Dong L; Qin S; Huang H
    Int J Infect Dis; 2021 Feb; 103():364-369. PubMed ID: 33278623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
    Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
    Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study.
    Davies Forsman L; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar JW; Mansjö M; Hoffner S; Xu B; Schön T; Bruchfeld J
    BMJ Open; 2018 Oct; 8(9):e023899. PubMed ID: 30287613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis.
    Parsons TL; Marzinke MA; Hoang T; Bliven-Sizemore E; Weiner M; Mac Kenzie WR; Dorman SE; Dooley KE
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6747-57. PubMed ID: 25182637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot.
    la Marca G; Villanelli F; Malvagia S; Ombrone D; Funghini S; De Gaudio M; Fallani S; Cassetta MI; Novelli A; Chiappini E; de Martino M; Galli L
    J Pharm Biomed Anal; 2012; 67-68():86-91. PubMed ID: 22559989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dried blood spots: a new tool for tuberculosis treatment optimization.
    Vu DH; Alffenaar JW; Edelbroek PM; Brouwers JR; Uges DR
    Curr Pharm Des; 2011; 17(27):2931-9. PubMed ID: 21834763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.